Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis
Authors
Keywords
-
Journal
Rheumatology and Therapy
Volume 7, Issue 3, Pages 473-516
Publisher
Springer Science and Business Media LLC
Online
2020-07-31
DOI
10.1007/s40744-020-00219-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden
- (2019) Kathrine Lederballe Grøn et al. ANNALS OF THE RHEUMATIC DISEASES
- Comorbidities in Patients with Rheumatoid Arthritis and Their Association with Patient-reported Outcomes: Results of Claims Data Linked to Questionnaire Survey
- (2019) Andres Luque Ramos et al. JOURNAL OF RHEUMATOLOGY
- The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors
- (2019) Martina Biggioggero et al. Biomed Research International
- Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma
- (2019) Danielle Harmer et al. Frontiers in Endocrinology
- Parabrachial Interleukin-6 Reduces Body Weight and Food Intake and Increases Thermogenesis to Regulate Energy Metabolism
- (2019) Devesh Mishra et al. Cell Reports
- Effects of Sarilumab on Patient-Reported Impact of Rheumatoid Arthritis Using the Rheumatoid Arthritis Impact of Disease Scale
- (2019) Laure Gossec et al. JOURNAL OF RHEUMATOLOGY
- Targeting of IL-6-Relevant Long Noncoding RNA Profiles in Inflammatory and Tumorous Disease
- (2019) Juan Zhang et al. INFLAMMATION
- Patient preferences for rheumatoid arthritis treatment
- (2019) Betty Hsiao et al. CURRENT OPINION IN RHEUMATOLOGY
- 069 High baseline serum IL-6 identifies a subgroup of rheumatoid arthritis patients with rapid joint damage and clinical progression and predicts increased sarilumab treatment response
- (2019) Anita Boyapati et al. RHEUMATOLOGY
- Rheumatoid arthritis disease activity predicting incident clinically‐apparent RA ‐associated interstitial lung disease: A prospective cohort study
- (2019) Jeffrey A. Sparks et al. Arthritis & Rheumatology
- STAT3: A Promising Therapeutic Target in Multiple Myeloma
- (2019) Chong et al. Cancers
- Changes to Body Composition in Women With Long-Standing Established Rheumatoid Arthritis: Differences by Level of Disease Activity
- (2019) Gabriela D. Carvalho et al. JOURNAL OF CLINICAL DENSITOMETRY
- Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years’ follow-up
- (2019) Roy Fleischmann et al. RHEUMATOLOGY
- Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial
- (2019) Jon T. Giles et al. Arthritis & Rheumatology
- Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab
- (2019) Sakiko Tabata et al. INTERNAL MEDICINE
- Overall infection risk in rheumatoid arthritis during treatment with abatacept, rituximab and tocilizumab; an observational cohort study
- (2019) Kathrine L Grøn et al. RHEUMATOLOGY
- Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
- (2018) Andrew I Rutherford et al. ANNALS OF THE RHEUMATIC DISEASES
- Rheumatoid arthritis and citrullination
- (2018) Erika Darrah et al. CURRENT OPINION IN RHEUMATOLOGY
- Safety and effectiveness of subcutaneous tocilizumab in patients with rheumatoid arthritis in a real-world clinical setting
- (2018) Tatsuya Atsumi et al. Modern Rheumatology
- The B cell response to citrullinated antigens in the development of rheumatoid arthritis
- (2018) Hans Ulrich Scherer et al. Nature Reviews Rheumatology
- How advances in personalized medicine will change rheumatology
- (2018) Carlo Selmi et al. Personalized Medicine
- Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study
- (2018) Yukimi Otsuka et al. PLoS One
- Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes
- (2018) Mark C Genovese et al. RHEUMATOLOGY
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- Anti-interleukin-6 receptor antibody prevents loss of bone structure and bone strength in collagen-induced arthritis mice
- (2018) H Yoshida et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registry
- (2018) Ennio Giulio Favalli et al. Drug Design Development and Therapy
- Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis
- (2018) Margarida Figueiredo-Braga et al. Journal of Immunology Research
- Circadian rhythms and rheumatoid arthritis
- (2018) Cutolo Maurizio JOINT BONE SPINE
- Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study
- (2018) T Matsuo et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- High Prevalence of Comorbid Autoimmune Diseases in Adults with Type 1 Diabetes from the HealthFacts Database
- (2018) Yicheng K Bao et al. Journal of Diabetes
- Prevalence of rheumatoid cachexia in rheumatoid arthritis: a systematic review and meta-analysis
- (2018) Rafaela C.E. Santo et al. Journal of Cachexia Sarcopenia and Muscle
- Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial
- (2018) Laura Bazzichi et al. CLINICAL RHEUMATOLOGY
- Comparison of patient and physician perspectives in the management of rheumatoid arthritis: results from global physician- and patient-based surveys
- (2018) Allan Gibofsky et al. Health and Quality of Life Outcomes
- Pulmonary arterial hypertension in adult-onset Still's disease: A case series and systematic review of the literature
- (2018) Javier Narváez et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection
- (2018) Martina Biggioggero et al. Drug Design Development and Therapy
- Effects of tocilizumab on neutrophil function and kinetics
- (2017) Laurence S. C. Lok et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The role and therapeutic targeting of IL-6 in rheumatoid arthritis
- (2017) Masashi Narazaki et al. Expert Review of Clinical Immunology
- Tocilizumab-induced hypofibrinogenemia: A report of 7 cases
- (2017) Nihal Martis et al. JOINT BONE SPINE
- RANKL: A therapeutic target for bone destruction in rheumatoid arthritis
- (2017) Sakae Tanaka et al. Modern Rheumatology
- High prevalence of diabetes in patients with rheumatoid arthritis: results from a questionnaire survey linked to claims data
- (2017) Katinka Albrecht et al. RHEUMATOLOGY
- Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
- (2017) Fabrizio Cantini et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
- (2017) Maria Gabriella Raimondo et al. Drug Design Development and Therapy
- Interleukin 6 Inhibition and Coronary Artery Disease in a High‐Risk Population: A Prospective Community‐Based Clinical Study
- (2017) Bruno Cesar Bacchiega et al. Journal of the American Heart Association
- Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis
- (2017) Anne Tournadre et al. Journal of Cachexia Sarcopenia and Muscle
- Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut–microbiota–brain axis
- (2017) J-c Zhang et al. Translational Psychiatry
- Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors
- (2017) Roy Fleischmann et al. Arthritis & Rheumatology
- Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis
- (2017) Yi-Ming Chen et al. PLoS One
- The brain needs interleukin-6 (IL-6) to maintain a “healthy” energy balance. Focus on “IL-6 ameliorates defective leptin sensitivity in DIO ventromedial hypothalamic nucleus neurons”
- (2016) Thomas A. Lutz AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial
- (2016) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
- (2016) R Agca et al. ANNALS OF THE RHEUMATIC DISEASES
- Comorbidities in rheumatoid arthritis
- (2016) Maxime Dougados CURRENT OPINION IN RHEUMATOLOGY
- IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice
- (2016) Juri Bergmann et al. HEPATOLOGY
- Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA
- (2016) Hisham Abdallah et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registry
- (2016) Andrea Becciolini et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial
- (2016) Johannes W J Bijlsma et al. LANCET
- Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
- (2016) Dinesh Khanna et al. LANCET
- Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials
- (2016) Robert J. Moots et al. RHEUMATOLOGY
- Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis
- (2016) Fabrizio Cantini et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review
- (2016) Andrea Picchianti Diamanti et al. Therapeutic Advances in Respiratory Disease
- Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
- (2015) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis
- (2015) A Richter et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
- (2015) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
- (2015) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
- (2015) Rita Haapakoski et al. BRAIN BEHAVIOR AND IMMUNITY
- The prevalence of severe fatigue in rheumatic diseases: an international study
- (2015) Cécile L. Overman et al. CLINICAL RHEUMATOLOGY
- Cytokines in rheumatoid arthritis — shaping the immunological landscape
- (2015) Iain B. McInnes et al. Nature Reviews Rheumatology
- Interleukin-6 as a predictor of symptom resolution in psychological distress: a cohort study
- (2015) M. Virtanen et al. PSYCHOLOGICAL MEDICINE
- Comment on: Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice: reply
- (2015) C. Fortunet et al. RHEUMATOLOGY
- Immunogenicity of biologic agents in rheumatoid arthritis patients: lessons for clinical practice
- (2015) Thierry Schaeverbeke et al. RHEUMATOLOGY
- Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients
- (2015) Helen Benham et al. Science Translational Medicine
- Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
- (2015) Ryoko Sakai et al. ARTHRITIS RESEARCH & THERAPY
- Reply
- (2015) Maxime Dougados Arthritis & Rheumatology
- Risk of Incident Diabetes Associated with Dose and Duration of Oral Glucocorticoid Therapy in Patients with Rheumatoid Arthritis
- (2015) Mohammad Movahedi et al. Arthritis & Rheumatology
- Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study
- (2015) Mark C. Genovese et al. Arthritis & Rheumatology
- Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?
- (2015) Xin Du et al. Frontiers in Psychiatry
- The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study
- (2014) Marita Cross et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate for the treatment of rheumatoid arthritis in the biologic era: Still an “anchor” drug?
- (2014) Ennio Giulio Favalli et al. AUTOIMMUNITY REVIEWS
- Open questions in autoimmunity: discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting
- (2014) Carlo Selmi et al. BMC Medicine
- Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort
- (2014) Elena Nikiphorou et al. CLINICAL RHEUMATOLOGY
- Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders
- (2014) Waseem Hassan et al. CYTOKINE
- Establishing a Core Domain Set to Measure Rheumatoid Arthritis Flares: Report of the OMERACT 11 RA Flare Workshop
- (2014) V. P. Bykerk et al. JOURNAL OF RHEUMATOLOGY
- The effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritis
- (2014) K. Kume et al. RHEUMATOLOGY
- Subcutaneous Tocilizumab Versus Placebo in Combination With Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis
- (2014) Alan Kivitz et al. ARTHRITIS CARE & RESEARCH
- The disease formerly known as rheumatoid arthritis
- (2014) Gary S Firestein ARTHRITIS RESEARCH & THERAPY
- A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)
- (2013) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin 6 Blockade–Associated Weight Gain With Abdominal Enlargement in a Patient With Rheumatoid Arthritis
- (2013) Said Younis et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Patient Perceptions concerning Pain Management in the Treatment of Rheumatoid Arthritis
- (2013) P Taylor et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Tocilizumab Inhibits Structural Joint Damage and Improves Physical Function in Patients with Rheumatoid Arthritis and Inadequate Responses to Methotrexate: LITHE Study 2-year Results
- (2013) R. M. FLEISCHMANN et al. JOURNAL OF RHEUMATOLOGY
- Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure
- (2013) M. C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis
- (2013) A. De Lauretis et al. JOURNAL OF RHEUMATOLOGY
- Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
- (2013) Cem Gabay et al. LANCET
- Cytokine patterns in patients with cancer: a systematic review
- (2013) Bodo E Lippitz LANCET ONCOLOGY
- The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis
- (2013) F. Matcham et al. RHEUMATOLOGY
- Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study
- (2013) Anne C. Bay-Jensen et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Interleukin-6: From basic biology to selective blockade of pro-inflammatory activities
- (2013) Jürgen Scheller et al. SEMINARS IN IMMUNOLOGY
- Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients
- (2013) Soken-Nakazawa J Song et al. ARTHRITIS RESEARCH & THERAPY
- Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis
- (2013) John D Isaacs et al. ARTHRITIS RESEARCH & THERAPY
- Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory Diseases
- (2013) Ricardo C. Ferreira et al. PLoS Genetics
- Glucocorticoid Dose Thresholds Associated With All-Cause and Cardiovascular Mortality in Rheumatoid Arthritis
- (2013) Inmaculada del Rincón et al. Arthritis & Rheumatology
- Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies
- (2012) Juan Antonio Avina-Zubieta et al. ANNALS OF THE RHEUMATIC DISEASES
- Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)
- (2012) Maxime Dougados et al. ANNALS OF THE RHEUMATIC DISEASES
- Spinal interleukin-6 is an amplifier of arthritic pain in the rat
- (2012) Enrique Vazquez et al. ARTHRITIS AND RHEUMATISM
- Review: Central pain mechanisms in the rheumatic diseases: Future directions
- (2012) Kristine Phillips et al. ARTHRITIS AND RHEUMATISM
- Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry
- (2012) Fabiola Atzeni et al. AUTOIMMUNITY REVIEWS
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- Anaemia in inflammatory rheumatic diseases
- (2012) Günter Weiss et al. Nature Reviews Rheumatology
- IL-6 Receptor Inhibition Positively Modulates Bone Balance in Rheumatoid Arthritis Patients with an Inadequate Response to Anti-Tumor Necrosis Factor Therapy: Biochemical Marker Analysis of Bone Metabolism in the Tocilizumab RADIATE Study (NCT00106522)
- (2012) Morten A. Karsdal et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine
- (2012) Elisa Gremese et al. ARTHRITIS CARE & RESEARCH
- Anxiety is more common than depression among US adults with arthritis
- (2012) Louise B. Murphy et al. ARTHRITIS CARE & RESEARCH
- Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
- (2011) E. Myasoedova et al. ANNALS OF THE RHEUMATIC DISEASES
- Co-morbidities in established rheumatoid arthritis
- (2011) Nicola J. Gullick et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Increased serum levels of β2-GPI-Lp(a) complexes and their association with premature atherosclerosis in patients with rheumatoid arthritis
- (2011) Chunni Zhang et al. CLINICA CHIMICA ACTA
- Tocilizumab Monotherapy Reduces Arterial Stiffness as Effectively as Etanercept or Adalimumab Monotherapy in Rheumatoid Arthritis: An Open-label Randomized Controlled Trial
- (2011) KENSUKE KUME et al. JOURNAL OF RHEUMATOLOGY
- Hypothalamic–pituitary–adrenal axis dysfunction in chronic fatigue syndrome
- (2011) Andrew S. Papadopoulos et al. Nature Reviews Endocrinology
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- The contribution of pain and depression to self-reported sleep disturbance in patients with rheumatoid arthritis
- (2011) Perry M. Nicassio et al. PAIN
- Interstitial lung disease in rheumatoid arthritis: response to IL-6R blockade
- (2011) M Mohr et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: Results of a maximum difference scaling experiment
- (2011) L. T. C. van Hulst et al. ARTHRITIS CARE & RESEARCH
- Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis
- (2011) Delphine S. Courvoisier et al. ARTHRITIS CARE & RESEARCH
- Integrated safety in tocilizumab clinical trials
- (2011) Michael H Schiff et al. ARTHRITIS RESEARCH & THERAPY
- Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
- (2010) G. R. Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab
- (2010) A. Ogata et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population-based study
- (2010) Tim Bongartz et al. ARTHRITIS AND RHEUMATISM
- Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu
- (2010) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- Association of IL-6, Hypothalamus-Pituitary-Adrenal Axis Function, and Depression in Patients With Cancer
- (2010) Christian Friedrich Jehn et al. INTEGRATIVE CANCER THERAPIES
- Rheumatoid arthritis and bone mineral density in elderly women
- (2010) Nancy E. Lane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases
- (2010) Olaf Schultz et al. PLoS One
- Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly
- (2010) J. B. Galloway et al. RHEUMATOLOGY
- Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis
- (2009) E. Lie et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
- (2009) G. Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Rapid and sustained improvement in bone and cartilage turnover markers with the antiâinterleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone
- (2009) Patrick Garnero et al. ARTHRITIS AND RHEUMATISM
- A Meta-Analysis of Cytokines in Major Depression
- (2009) Yekta Dowlati et al. BIOLOGICAL PSYCHIATRY
- Spinally applied ketamine or morphine attenuate peripheral inflammation and hyperalgesia in acute and chronic phases of experimental arthritis
- (2009) Michael Karl Boettger et al. BRAIN BEHAVIOR AND IMMUNITY
- On the origins of complex immune-mediated disease: the example of rheumatoid arthritis
- (2009) Lars Klareskog et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation
- (2008) V P van Halm et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)
- (2008) Aramesh Saremi et al. ATHEROSCLEROSIS
- Serious infections during anti-TNFα treatment in rheumatoid arthritis patients
- (2008) Ennio Giulio Favalli et al. AUTOIMMUNITY REVIEWS
- Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
- (2008) N. Nishimoto et al. BLOOD
- C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease
- (2008) P. M Ridker CLINICAL CHEMISTRY
- Interleukin-6 Directly Inhibits Osteoclast Differentiation by Suppressing Receptor Activator of NF-κB Signaling Pathways
- (2008) Fumio Yoshitake et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Functional polymorphisms in the interleukin-6 and serotonin transporter genes and depression and fatigue induced by interferon-α and ribavirin treatment
- (2008) S J Bull et al. MOLECULAR PSYCHIATRY
- Role of Interleukin-6 in the Anemia of Chronic Disease
- (2008) Dominic S.C. Raj SEMINARS IN ARTHRITIS AND RHEUMATISM
- The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
- (2008) Willscott E. Naugler et al. TRENDS IN MOLECULAR MEDICINE
- A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
- (2008) Allison L Smitten et al. ARTHRITIS RESEARCH & THERAPY
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review
- (2008) John Danesh et al. PLOS MEDICINE
- Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
- (2007) A Gonzalez et al. ANNALS OF THE RHEUMATIC DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search